Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 3
2017 1
2018 8
2019 4
2020 10
2021 14
2022 13
2023 22
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy for Melanoma.
Albittar AA, Alhalabi O, Glitza Oliva IC. Albittar AA, et al. Among authors: alhalabi o. Adv Exp Med Biol. 2020;1244:51-68. doi: 10.1007/978-3-030-41008-7_3. Adv Exp Med Biol. 2020. PMID: 32301010 Review.
Evolving systemic management of urothelial cancers.
Tan WS, Tan MY, Alhalabi O, Campbell MT, Kamat AM, Gao J. Tan WS, et al. Among authors: alhalabi o. Curr Opin Oncol. 2023 May 1;35(3):186-199. doi: 10.1097/CCO.0000000000000942. Epub 2023 Mar 14. Curr Opin Oncol. 2023. PMID: 36966497 Review.
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.
Han G, Yang G, Hao D, Lu Y, Thein K, Simpson BS, Chen J, Sun R, Alhalabi O, Wang R, Dang M, Dai E, Zhang S, Nie F, Zhao S, Guo C, Hamza A, Czerniak B, Cheng C, Siefker-Radtke A, Bhat K, Futreal A, Peng G, Wargo J, Peng W, Kadara H, Ajani J, Swanton C, Litchfield K, Ahnert JR, Gao J, Wang L. Han G, et al. Among authors: alhalabi o. Nat Commun. 2021 Sep 23;12(1):5606. doi: 10.1038/s41467-021-25894-9. Nat Commun. 2021. PMID: 34556668 Free PMC article.
Reply by Authors.
Hensley PJ, Bree KK, Campbell MT, Alhalabi O, Kokorovic A, Miest T, Nogueras-Gonzalez GM, Gao J, Siefker-Radtke AO, Guo CC, Navai N, Dinney CP, Kamat AM. Hensley PJ, et al. Among authors: alhalabi o. J Urol. 2021 Nov;206(5):1267. doi: 10.1097/JU.0000000000001943.02. Epub 2021 Aug 10. J Urol. 2021. PMID: 34372685 No abstract available.
Emerging treatments in advanced urothelial cancer.
Alhalabi O, Campbell M, Shah A, Siefker-Radtke A, Gao J. Alhalabi O, et al. Curr Opin Oncol. 2020 May;32(3):232-239. doi: 10.1097/CCO.0000000000000618. Curr Opin Oncol. 2020. PMID: 32209822 Review.
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies.
Alhalabi O, Groisberg R, Zinner R, Hahn AW, Naing A, Zhang S, Tsimberidou AM, Rodon J, Fu S, Yap TA, Hong DS, Sun M, Jiang Y, Pant S, Shah AY, Zurita A, Tannir NM, Vikram R, Roszik J, Meric-Bernstam F, Subbiah V. Alhalabi O, et al. NPJ Precis Oncol. 2023 Apr 18;7(1):37. doi: 10.1038/s41698-023-00369-w. NPJ Precis Oncol. 2023. PMID: 37072571 Free PMC article. Review.
Landscape of Immunotherapy in Genitourinary Malignancies.
Ravindranathan D, Alhalabi O, Rafei H, Shah AY, Bilen MA. Ravindranathan D, et al. Among authors: alhalabi o. Adv Exp Med Biol. 2021;1342:143-192. doi: 10.1007/978-3-030-79308-1_5. Adv Exp Med Biol. 2021. PMID: 34972965 Review.
The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review.
Machado AP, Ratliff H, Abdelwahab A, Vohra MH, Kuang A, Shatila M, Khan MA, Shafi MA, Thomas AS, Philpott J, Alhalabi O, Wang Y. Machado AP, et al. Among authors: alhalabi o. J Cancer. 2023 Sep 11;14(16):2956-2963. doi: 10.7150/jca.87335. eCollection 2023. J Cancer. 2023. PMID: 37859810 Free PMC article. Review.
73 results